Evidence map›Paper›PMID 42851879›Full record

ArticleACS omega2026

Highly Selective Thiazole Derivatives as Promising Anti-

Ingrid de Oliveira Dias, Gabriel Cândido Moura, Lucas Manoel da Silva Sousa, Rafael Meyer Mariante, Ana Cristina Lima Leite, Juliana Quero Reimão

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ingrid de Oliveira DiasFaculdade de Medicina de Jundiaí, Laboratory of Preclinical Assays and Research of Alternative Sources of Innovative Therapy for Toxoplasmosis and Other Sicknesses (PARASITTOS), Rua Francisco Telles 250, 13202-550 Jundiaí, Brazil.
Gabriel Cândido MouraFaculdade de Medicina de Jundiaí, Laboratory of Preclinical Assays and Research of Alternative Sources of Innovative Therapy for Toxoplasmosis and Other Sicknesses (PARASITTOS), Rua Francisco Telles 250, 13202-550 Jundiaí, Brazil.ORCID https://orcid.org/0000-0002-1256-057X
Lucas Manoel da Silva SousaFederal University of Pernambuco, Department of Pharmaceutical Sciences, Avenida Artur de Sá S/N, 50740-520 Recife, Brazil.ORCID https://orcid.org/0009-0000-4233-4066
Rafael Meyer MarianteInstituto Oswaldo Cruz, Laboratory of Structural Biology, Avenida Brasil 4365, 21040-360 Rio de Janeiro, Brazil.
Ana Cristina Lima LeiteFederal University of Pernambuco, Department of Pharmaceutical Sciences, Avenida Artur de Sá S/N, 50740-520 Recife, Brazil.ORCID https://orcid.org/0000-0002-9346-2292
Juliana Quero ReimãoFaculdade de Medicina de Jundiaí, Laboratory of Preclinical Assays and Research of Alternative Sources of Innovative Therapy for Toxoplasmosis and Other Sicknesses (PARASITTOS), Rua Francisco Telles 250, 13202-550 Jundiaí, Brazil.ORCID https://orcid.org/0000-0002-4418-0838

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Toxoplasmosis, caused by the protozoan

Identifiers

PMID42851879
PMCPMC13647394

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.